G Medical Innovations Holdings Ltd (GMVD)
Market Cap | 3.79M |
Revenue (ttm) | 4.42M |
Net Income (ttm) | 13.52M |
Shares Out | 9.84M |
EPS (ttm) | -34.17 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 311,620 |
Open | 0.381 |
Previous Close | 0.411 |
Day's Range | 0.365 - 0.420 |
52-Week Range | 0.340 - 41.300 |
Beta | -1.02 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Jun 6, 2023 |
About GMVD
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for... [Read more]
Financial Performance
In 2022, GMVD's revenue was $4.42 million, a decrease of -10.91% compared to the previous year's $4.96 million. Earnings were $13.52 million, a decrease of -6.47%.
Financial StatementsNews

G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
Rehovot, Israel, May 19, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company, announced to...

G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Hearings Panel's Decision to Grant Exception for Continued Listing
Rehovot, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”) announced today that, on May 11, 2023, the Company received notice from the Hearing...

G MEDICAL UPDATES ON PATIENT ENROLLMENT GROWTH FOR ITS HOME MONITORING SERVICES OF 194% FROM JANUARY THROUGH APRIL 2023, AS COMPARED TO THE SAME PERIOD IN 2022
Rehovot, Israel, April 18, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical"), a global leader in next-generation mobile health (mHealth) and di...

G Medical Innovations Holdings Ltd. Announces Closing of Public Offering
Rehovot, Israel, April 04, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a global leader in next-generation mobile health (mHealth) and digital health, t...

G Medical Innovations Holdings Ltd. Announces Pricing of Public Offering
Rehovot, Israel, March 31, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a global leader in next-generation mobile health (mHealth) and digital health, t...

G MEDICAL INNOVATIONS AND MICARE PATH ANNOUNCE JOINT COLLABORATION TO PROVIDE INNOVATIVE REMOTE PATIENT MONITORING SOLUTIONS GLOBALLY
Rehovot, Israel, March 27, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”), a global leader in next-generation mobile health (mH...

G Medical Innovations Holdings Ltd Announces Nasdaq Staff Listing Determination; Plans to Request Hearing
Rehovot, Israel, Feb. 17, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”) announced today that on February 16, 2023, the Company received notice from the Li...

G Medical Innovations announces receipt of patent from USPTO for vital signs sensors
Rehovot, Israel, Feb. 13, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”) today announced that the patent US 11,571,167 “Method a...

G Medical Innovations announces receiving notice of patent issuance from the USPTO for vital signs sensors
Rehovot, Israel, Jan. 30, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”) today announced that it has received a patent issue not...

Bronstein, Gewirtz & Grossman, LLC Announces G Medical Holdings Ltd (GMVD) Investigation
NEW YORK , Dec. 7, 2022 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against G Medical Holdings Ltd ("G Medical" or the "Company") (NASD...

G Medical Innovations to announce receiving of 2 (two) granted patents from the USPTO for its Prizma care and other physiological sensors developed by the company.
Irvine, California, Dec. 05, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company” or “G Medical Innovations”) today announced that it received 2 (Two) granted pat...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of G Medical Holdings Ltd - GMVD
New York, New York--(Newsfile Corp. - November 30, 2022) - Pomerantz LLP is investigating claims on behalf of investors of G Medical Holdings Ltd ("G Medical" or the "Company") (NASDAQ: GMVD). Such in...

G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Notice of Deficiency with Nasdaq Continued Listing Requirements
Irvine, California, Nov. 22, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing ...

G Medical Innovations Announces First Half 2022 Financial Results and Provides Business Update
Irvine, CA, Nov. 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical” or the “Company”), an early commercial stage healthcare company engaged in the development...

G Medical Innovations is introducing a Monkeypox consumer home health test kit, along with 30 new direct to consumer home health testing kits with 24 to 48 hours results
October 6, 2022

G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick results
The first 7 new health testing kits covering Food sensitivity (96 and 208 types of food), indoor/outdoor allergies, Thyroid functioning, testosterone levels, HbA1C and HPV tests will be available for ...

G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Nasdaq Minimum Bid Price Notification
Irvine, California, June 17, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing ...

G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) Announces Share Repurchase Program
Irvine, California, May 20, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company”) today announced that its board of directors has authorized a share repurchase pr...

(Correction) G Medical Innovations Holdings Ltd Announces $7.5 Million Private Placement
TEL AVIV and NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providi...

G Medical Innovations' Subsidiary Expands COVID-19 Testing To Additional Locations In California
G Medical Innovations Holdings Ltd's (NASDAQ: GMVD) subsidiary, G Medical Tests and Services Inc, expanded its COVID-19 testing services to more than 150+ additional locations across California. The ...

Argus Research Initiates Equity Research Report Coverage on G Medical Innovations Holdings Ltd. (NASDAQ: GMVD)
NEW YORK, Dec. 13, 2021 /PRNewswire/ -- Argus Research, an independent investment research firm, has launched Equity Research Report coverage on G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) Cli...

G Medical Innovations: A Hidden Med-Tech Gem
The Covid-19 crisis has brought a number of changes in the way healthcare providers do business, including the incorporation of digitalization, resulting in a significant rise in the valuations of tel...

G Medical Innovations Holdings Ltd. Reports Financial Results for the Six Months Ended June 30, 2021, with Revenue up 45.5%
Demand for patient monitoring services recovering with revenue increasing 45.5% in first half of 2021 Accelerating growth strategy with expansion of Prizma and Cardiac sales team

G Medical Innovations: The Next Generation of Healthcare for Caregivers and Patients
Photo by Online Marketing on Unsplash If the coronavirus pandemic taught the world anything, it was how important healthcare is to everyone. With the virus still posing a serious threat, some people m...

SmallCapsDaily: G Medical Innovations is an Ideal Blend of Growth and Profitability
New York, New York--(Newsfile Corp. - September 8, 2021) - G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company provi...